News Daily News Most Carotid Ultrasounds Performed for Uncertain or Inappropriate Indications Michael O'Riordan April 19, 2016
News Daily News Another CV Outcomes Trial Testing Weight-Loss Drug Contrave Terminated Early Michael O'Riordan April 14, 2016
News Daily News FDA Approves Impella Left-Ventricular Heart Pumps for Cardiogenic Shock Michael O'Riordan April 08, 2016
News Conference News ACC 2016 Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon Michael O'Riordan April 06, 2016
News Conference News ACC 2016 STEPATHLON: A Mobile-Based Exercise Program Increased Physical Activity and Promoted Weight Loss Michael O'Riordan April 04, 2016
News Conference News ACC 2016 ‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study Michael O'Riordan April 04, 2016
News Conference News ACC 2016 Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH Michael O'Riordan April 03, 2016
News Conference News ACC 2016 HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not Michael O'Riordan April 02, 2016
News Daily News ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors Michael O'Riordan April 02, 2016
News Daily News ACC actualiza las recomendaciones para bajar el colesterol LBD, abriendo un espacio para el uso de Ezetimibe y de los inhibidores de PCSK9 Michael O'Riordan April 02, 2016
News Daily News Publica la AHA declaración sobre los desfibriladores portátiles y advierte que los datos sobre su eficacia son limitados Michael O'Riordan March 31, 2016
News Daily News AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited Michael O'Riordan March 31, 2016
News Daily News AVB Absorb: Seguridad, Eficacia y Trombosis del Stent a Estudio en 2 Nuevos Análisis Michael O'Riordan March 30, 2016
News Daily News Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses Michael O'Riordan March 30, 2016
News Daily News Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs Michael O'Riordan March 25, 2016
News Daily News Cada Vez Más Evidencias Confirman que No hay un Mayor Riesgo de Insuficiencia Cardíaca asociado a los Fármacos Antidiabéticos basados en la Incretina Michael O'Riordan March 25, 2016